We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03516981
Brief Title: A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)

First Submitted : April 27, 2018
First Submitted that Met QC Criteria : April 27, 2018
First Posted : May 7, 2018

Last Update Submitted that Met QC Criteria : August 23, 2022
Last Update Posted : August 26, 2022